tiprankstipranks
Galera Therapeutics (GRTX)
OTHER OTC:GRTX
US Market

Galera Therapeutics (GRTX) Income Statement

Compare
263 Followers

Galera Therapeutics Income Statement

Last quarter (Q3 2024), Galera Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Galera Therapeutics's net income was $-5.58M. See Galera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -259.00K$ -114.00K$ -778.00K$ -368.00K$ -267.00K
Operating Expenses
$ 46.69M$ 51.23M$ 73.37M$ 70.55M$ 50.69M
Depreciation and Amortization
$ 259.00K$ 114.00K$ 778.00K$ 368.00K$ 267.00K
EBITDA
$ -46.69M$ -50.61M$ -72.56M$ -69.01M$ -50.69M
Operating Income
$ -46.95M$ -51.23M$ -73.37M$ -70.55M$ -50.69M
Other Income/Expenses
$ -12.13M$ -11.07M$ -7.17M$ -3.68M$ -1.25M
Pretax Income
$ -59.08M$ -62.29M$ -80.53M$ -74.23M$ -51.94M
Net Income
$ -59.08M$ -62.22M$ -87.73M$ -74.22M$ -51.93M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.33$ -2.30$ -3.40$ -2.98$ -2.09
Diluted EPS
$ -1.33$ -2.30$ -3.40$ -2.98$ -2.09
Weighted Average Shares Outstanding
44.55M 27.09M 25.79M 24.87M 24.81M
Weighted Average Shares Outstanding (Diluted)
44.55M 27.09M 25.79M 24.87M 24.81M
Currency in USD

Galera Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis